Smartleaf Asset Management »

Urogen Pharma shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4k 72 19.14

More positions owned by Smartleaf Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard World Mega Cap Val Etf (MGV)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
JPMorgan Chase & Co. (JPM)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Wisdomtree Tr Us Quality Grow (QGRW)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Smartleaf Asset Management

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Morgan Stanley
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
Acorn Capital Advisors
SG Americas Securities
Menora Mivtachim Holdings
Caption Management
Tang Capital Management
D. E. Shaw & Co
State Street Corporation

View all funds holding Urogen Pharma